Abstract
This paper shows that the exogenous delta-sleep-inducing peptide (DSIP) injected subcutaneously into rats at an age of 2–24 months of postnatal development in a dose of 100 mg/kg of animal body weight in courses for five consecutive days each month has a hepatoprotective effect. DSIP does not affect the functional activity of the pancreas and is not involved in the regulation of calcium homeostasis in the physiological aging of an organism.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
